Navigation Links
Pacific Meso Center Receives Generous Donation to First Free-Standing Mesothelioma Research Laboratory in Los Angeles
Date:12/23/2011

LOS ANGELES, Dec. 23, 2011 /PRNewswire/ -- Pacific Meso Center (PMC) at the Pacific Heart, Lung & Blood Institute (PHLBI) announces a generous donation of $100,000 from Roger and Ann Worthington. Mr. Worthington is the founding partner of The Law Office of Roger G. Worthington, PC, an asbestos law firm in San Pedro. The $100,000 will go towards PMC's new laboratory in Santa Monica, California. The new state-of-the-art mesothelioma research laboratory is dedicated solely to the discovery of new treatments for malignant pleural mesothelioma, and will focus not only on the development of novel treatments for mesothelioma but also on its prevention.

"Our pledge of support for this laboratory has come as a result of the end of the conflict in Iraq and to honor our country's surviving veterans, whether from WWII, the Korean War, the Vietnam War, or more recent conflicts, who were exposed to deadly asbestos fibers," said Roger Worthington. "Many of those veterans have gone on to be diagnosed with malignant pleural mesothelioma, an asbestos-related cancer of the chest lining and for which there are few treatment options," he added.

A team of physicians and scientists are launching research at the lab including one of the foremost experts in the field of mesothelioma research and treatment, Robert B. Cameron, M.D. Dr. Cameron is a cardiothoracic surgeon and surgical oncologist, the director of the UCLA Comprehensive Mesothelioma Program at the David Geffen School of Medicine at UCLA, Chief of Thoracic Surgery at the West Los Angeles Veterans' Administration Medical Center, and a long-time proponent of lung-sparing surgery for malignant pleural mesothelioma.

"Unfortunately, within the colossal VA system, treating mesothelioma patients is not a priority. Despite an annual budget of over $132 billion (2012), the VA has neither a research nor a treatment program for vets stricken with war-related mesothelioma," said Roger Worthington. Dr. Robert Cameron adds: "We are preparing to ask the VA to live up to its obligations to provide the best medical care for these veterans suffering from mesothelioma by creating a national center of excellence for both research and treatment at the West Los Angeles VA Medical Center where any veteran from across the country can come and be treated with the most advanced medical treatment available worldwide. We not only can, but we must, finally do this for our veterans."

As the first of its kind in the world, the research lab was established to lead a focused and collaborative mesothelioma research effort that is independent of the limitations often imposed by academic as well as private medical institutions. Other important initial projects for PMC will include the establishment of an international tissue bank, the development of intraoperative cryotherapy (freezing), initiation of a stromal cell modification project (stromal cells are the connective tissue cells of any organ) and the identification of a predictive model for drug prevention of malignant pleural mesothelioma.

About the Pacific Meso Center:

The Pacific Meso Center (PMC) is a division of the Pacific Heart, Lung & Blood Institute, a 501(c)(3) non-profit medical research institute established in 2002 which is focused on the treatment and prevention of malignant pleural mesothelioma (MPM). 

For further information, please contact:

Clare Cameron
310-478-4678
http://www.pacificmesocenter.org or http://www.phlbi.org  
ccameron@phlbi.org

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.  


'/>"/>
SOURCE Pacific Meso Center
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. CoreValve Successfully Treats the First Pacific Rim Patients with Its ReValving System for Percutaneous Aortic Valve Replacement : Australia/New Zealand Regulatory-Cleared Evaluation Registry is Expected to Lead to Market Clearance for These Countries
2. Quintiles Expands Base for Growing Asia-Pacific Operations
3. Simcere Pharmaceutical Group to Participate in Morgan Stanley Seventh Annual Asia Pacific Summit 2008
4. PacificGMP and Actinium Pharmaceuticals Announce Agreements for cGMP Antibody Manufacturing and Stability Testing
5. Pacific Northwest National Laboratories Becomes a GeneGo Center of Excellence
6. Queensland Facility for Advanced Bioinformatics (QFAB) Becomes a GeneGo Center of Excellence for the Asia Pacific Region
7. PacificGMP and LigoCyte Pharmaceuticals Announce cGMP Manufacturing Collaboration
8. Sundia MediTech in Deloitte Technology Fast 500 Asia Pacific List
9. Copan Announces the Appointment of Bob Cooper as Vice President of Business Development in the Pacific Rim
10. OmniComm Systems Appoints EDC Veteran Dr. Wolfgang Summa to Executive Vice President, Europe & Asia/Pacific
11. Dendreon Corporation CEO Mitchell H. Gold, M.D. Named Ernst & Young Entrepreneur of the Year(R) 2009 Award Finalist in the Pacific Northwest
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the ... major shareholders, Clean Technology Fund I, LP and Clean ... based venture capital funds which together hold approximately ... fully diluted, as converted basis), that they have entered ... equity holdings in Biorem to TUS Holdings Co. Ltd. ...
(Date:6/27/2016)... Diego, CA (PRWEB) , ... June 27, 2016 , ... ... solutions for clinical trials, announced today the Clinical Reach Virtual Patient Encounter ... their care circle with the physician and clinical trial team. , Using the CONSULT ...
(Date:6/27/2016)... June 27, 2016  Liquid Biotech ... funding of a Sponsored Research Agreement with The ... cells (CTCs) from cancer patients.  The funding will ... levels correlate with clinical outcomes in cancer patients ... will then be employed to support the design ...
(Date:6/24/2016)... , June 24, 2016 Epic ... sensitively detects cancers susceptible to PARP inhibitors by ... tumor cells (CTCs). The new test has already ... therapeutics in multiple cancer types. Over ... DNA damage response pathways, including PARP, ATM, ATR, ...
Breaking Biology Technology:
(Date:6/3/2016)... , June 3, 2016 ... von Nepal hat ... Lieferung hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, Registrierung ... in der Produktion und Implementierung von Identitätsmanagementlösungen. ... Ausschreibung im Januar teilgenommen, aber Decatur wurde ...
(Date:6/2/2016)... , June 2, 2016   The Weather Company ... announcing Watson Ads, an industry-first capability in which consumers will ... being able to ask questions via voice or text and ... Marketers have long sought an ... consumer, that can be personal, relevant and valuable; and can ...
(Date:6/1/2016)... 1, 2016 Favorable Government Initiatives ... and Criminal Identification to Boost Global Biometrics System Market ... TechSci Research report, " Global Biometrics Market By ... and Opportunities, 2011 - 2021", the global biometrics market ... on account of growing security concerns across various end ...
Breaking Biology News(10 mins):